ReviewFrontiers in immunology2023

Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer.

Danming He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.